299 related articles for article (PubMed ID: 35346200)
1. Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.
Ying HQ; Chen W; Xiong CF; Wang Y; Li XJ; Cheng XX
Cancer Cell Int; 2022 Mar; 22(1):137. PubMed ID: 35346200
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
[TBL] [Abstract][Full Text] [Related]
3. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
[TBL] [Abstract][Full Text] [Related]
4. Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients.
Sun F; Peng HX; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Wang XZ; Ying HQ
Cancer Manag Res; 2018; 10():2151-2161. PubMed ID: 30050325
[TBL] [Abstract][Full Text] [Related]
5. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer.
Ying HQ; Sun F; Liao YC; Cai D; Yang Y; Cheng XX
Ther Adv Med Oncol; 2021; 13():17588359211022886. PubMed ID: 34262615
[TBL] [Abstract][Full Text] [Related]
6. Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I-III Mucinous Colorectal Adenocarcinoma.
Liao YC; Ying HQ; Huang Y; Luo YR; Xiong CF; Nie RW; Li XJ; Cheng XX
Cancer Manag Res; 2021; 13():3455-3464. PubMed ID: 33907468
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer.
Zhang J; Li SQ; Liao ZH; Jiang YH; Chen QG; Huang B; Liu J; Xu YM; Lin J; Ying HQ; Wang XZ
Oncotarget; 2017 Sep; 8(43):75195-75205. PubMed ID: 29088857
[TBL] [Abstract][Full Text] [Related]
8. High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients.
Ying HQ; You XH; Liao YC; Sun F; Cheng XX
Front Oncol; 2021; 11():580455. PubMed ID: 33968712
[No Abstract] [Full Text] [Related]
9. The role of preoperative FPR and FAR in prognostic evaluation of stages II and III radical colorectal cancer: A single-center retrospective study.
Yan H; Liu T; Yu R; Xia D
Medicine (Baltimore); 2024 May; 103(20):e38145. PubMed ID: 38758911
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Preoperative Fibrinogen-to-Prealbumin Ratio in Patients with Stage I-III Colorectal Cancer Undergoing Surgical Resection: A Retrospective Cohort Study.
Hailun Xie ; Huang S; Yuan G; Tang S; Gan J
Biomed Res Int; 2021; 2021():3905353. PubMed ID: 33521127
[TBL] [Abstract][Full Text] [Related]
11. Combined fibrinogen-to-pre-albumin ratio and carbohydrate antigen 19-9 score is a promising metric to predict progression of metastatic colorectal mucinous adenocarcinoma.
Liao YC; Fu M; Wang XF; Cheng XX
J Clin Lab Anal; 2021 May; 35(5):e23757. PubMed ID: 33734488
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment Albumin-to-Fibrinogen Ratio is a Promising Biomarker for Predicting Postoperative Clinical Outcomes in Patients with Colorectal Cancer.
Xie H; Yuan G; Liu M; Huang S; Wei L; Tang S; Gan J
Nutr Cancer; 2022; 74(8):2896-2909. PubMed ID: 35193433
[TBL] [Abstract][Full Text] [Related]
13. Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA.
Fenqi D; Yupeng L; Qiuju Z; Chao Y; Wenjie S; Tianyi X; Junnan G; Weinan X; Xiufeng J; Junge B; Chenyang J; Hua X; Yien L; Xuefeng B; Yanlong L
Front Oncol; 2021; 11():758509. PubMed ID: 35087748
[TBL] [Abstract][Full Text] [Related]
14. Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients.
Chen QG; Zhang L; Sun F; Li SQ; You XH; Jiang YH; Yang WM; Zhong QH; Wang XZ; Ying HQ
Aging (Albany NY); 2019 Mar; 11(6):1716-1732. PubMed ID: 30897064
[TBL] [Abstract][Full Text] [Related]
15. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
16. Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC.
Ying HQ; Liao YC; Luo YR; Xiong G; Huang Y; Nie RW; Xiong CF; Cheng XX
Pharmacol Res; 2021 Aug; 170():105734. PubMed ID: 34157424
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
18. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
[TBL] [Abstract][Full Text] [Related]
19. Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer.
Chen C; Liu Y; Han P; Cui B
Cancer Manag Res; 2021; 13():1791-1801. PubMed ID: 33654428
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer.
Li X; Xiong Z; Xie M; Huang Q; Jin L; Yin S; Chen S; Lan P; Lian L
J Gastrointest Oncol; 2021 Aug; 12(4):1470-1481. PubMed ID: 34532103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
